Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Research
Molecular Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Highlights

Selected Articles from This Issue

DOI:  Published November 2020
  • Article
  • Info & Metrics
  • PDF
Loading

EphA2 Interacts with PLCγ1 in Lung Cancer

Song et al. Page 1735

Altered receptor tyrosine kinase (RTK) activity has long been recognized as a key source of pro-mitotic and pro-survival signals that support the proliferation of cancer cells. The RTK EphA2 is particularly known to be overexpressed and to contribute to tumorigenic signaling in lung cancer. However, the downstream signaling pathways that transduce EphA2 signaling into biological outcomes are not well understood. Here, Song and colleagues identify phospholipase Cγ1 (PLCγ1) Y783 as a key phosphorylation substrate and crucial signaling mediator downstream of EphA2. Perturbations of EphA2 and PLCγ1 expression and/or activity revealed that this axis was necessary for tumor proliferation in multiple models. Taken together, the data provide a foundation for developing interventions that target EphA2-PLCγ1 signaling for therapeutic benefit.

Stromal Regulation of Breast Cancer Invasion

Hanley et al. Page 1615

Heterotypic interactions between the tumor cells and the stromal compartment play a key role in guiding the development of tumor development and metastasis. Here, Hanley and colleagues report a dynamic regulatory feedback loop between breast cancer cells and their cognate stroma. By culturing breast cancer organoids alongside autologous fibroblasts, the authors observed an increase in keratin-14 (KRT14) expression in tumor cells. KRT14 expression marked a transcriptomic profile with basal epithelial characteristics and a propensity toward metastasis, regardless of whether the organoids were originally luminal- or basal-type. Importantly, conditioned medium from fibroblasts did not induce KRT14 expression: instead, it was found that TGF-β signaling from cancer cells to fibroblasts was necessary to induce NOX4 expression, which in turn induced KRT14 expression and alteration of the organoids' molecular phenotype. Taken together, the data elucidate a novel mechanism by which fibroblasts can influence tumor biology and progression.

RNF8 Promotes EMT in Lung Cancer

Kuang et al. Page 1638

Despite significant progress in recent decades, lung cancer remains the leading cause of cancer mortality and there is an ongoing clinical need to identify novel therapeutic targets. Ring finger protein 8 (RNF8), an E3 ubiquitin ligase with roles in DNA repair and spermatogenesis, was recently reported to contribute to breast cancer progression and metastasis. In this study, Kuang and colleagues identify RNF8 as a potential therapeutic target in lung cancer by virtue of a novel tumorigenic mechanism. RNF8 expression had significant bearing on cell motility, similar to its known role in breast cancer. Distinct from these earlier findings, however, RNF8 activity in lung cancer was found to be mediated through stabilization of the pro-metastatic transcription factor Slug. Specifically, RNF8 mediated Slug stabilization through ubiquitination of lysine residue 63, thus promoting PI3K/Akt signaling and epithelial–mesenchymal transition in lung cancer cells. Overall, the study provides new mechanistic insights into the role of RNF8 in cancer and nominate it as a potential therapeutic target to inhibit metastatic spread.

RCC2 Promotes Esophageal Tumor Growth through Sox2

Calderon-Aparicio et al. Page 1660

Esophageal cancer is a common and deadly malignancy whose incidence is increasing worldwide. In this study, Calderon-Aparicio and colleagues identify regulator of chromosome condensation 2 (RCC2) as a novel oncogene in esophageal cancer. Whereas RCC2 normally functions as a regulator of Aurora kinase B activity to mediate mitosis, the authors report that increased RCC2 expression in the esophagus served to activate the expression and activity of the oncogenic transcription factor Sox2. The RCC2-Sox2 network was shown to be crucial for the proliferation and migration of esophageal cancer cells in vitro. RCC2-Sox2 was also shown to be overexpressed in vivo, specifically in the esophageal basal cell layer, and was necessary for both the genesis and progression of esophageal cancer in mice. These data mechanistically demonstrate a novel role for RCC2 in esophageal cancer, which may be a candidate for the development of targeted interventions.

  • ©2020 American Association for Cancer Research.
PreviousNext
Back to top
Molecular Cancer Research: 18 (11)
November 2020
Volume 18, Issue 11
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Selected Articles from This Issue
(Your Name) has forwarded a page to you from Molecular Cancer Research
(Your Name) thought you would be interested in this article in Molecular Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Selected Articles from This Issue
Mol Cancer Res November 1 2020 (18) (11) 1613;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Selected Articles from This Issue
Mol Cancer Res November 1 2020 (18) (11) 1613;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • EphA2 Interacts with PLCγ1 in Lung Cancer
    • Stromal Regulation of Breast Cancer Invasion
    • RNF8 Promotes EMT in Lung Cancer
    • RCC2 Promotes Esophageal Tumor Growth through Sox2
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Selected Articles from This Issue
  • Selected Articles from This Issue
  • Selected Articles from This Issue
Show more Highlights
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement